HOUSTON--(BUSINESS WIRE)--Vyripharm Enterprises Inc. (VEI), a Texas biopharmaceutical/biotechnology company based in the Texas Medical Center (TMC) in Houston, and ABB Robotics, a leading global technology company headquartered in Zürich, Switzerland, have signed an agreement towards the development of an automated laboratory testing platform.

HOUSTON--(BUSINESS WIRE)--Vyripharm Enterprises Inc. and BIZPAC.US hosted the First Annual Vyripharm Public Health and Safety Legislative Reception on August 31, 2022 at the Texas Medical Center (TMC) Institute Innovation Factory, TMC's 1st phase biotech incubator and accelerator.

Drag View


Helping People Live Better Lives

Quality Assurance and Quality Control is Vyripharm’s focus for enhancing public safety, public health and public awareness.